WilliamPettyWilliam J. Petty MD36.09032400000000-80.266491000000001044Petty, WilliamJeffreyProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 391919Authorship 39804924444530Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyKilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014 Mar; 110(3):505-10.Radiother Oncol2014-01-17T00:00:002014Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.24736084Kilburn JM, Lester SC, Lucas JT, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerKilburn JM, Lester SC, Lucas JT, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer. J Thorac Oncol. 2014 Apr; 9(4):572-6.J Thorac Oncol2014-04-01T00:00:002014Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.Cancer BiologyDermatologyWake Forest School of Medicine1.592330.0174593140research areas0.9370340.030370142coauthor of26.55935.1556748similar to1127selected publicationsJimmyRuizJimmy Ruiz MD36.08959100000000-80.268599000000001119Ruiz, JimmyProfessorEdwardLevineEdward A. Levine MD36.08959100000000-80.26859900000000273Levine, EdwardProfessorElsayedSolimanElsayed Z. Soliman MD, MS36.09550200000000-80.24393700000000281Soliman, ElsayedProfessorGlennLesserGlenn J. Lesser MD36.08919100000000-80.26677800000000315Lesser, GlennProfessorJamesJordanJames E. Jordan PhD36.09032400000000-80.26649100000000407Jordan, JamesAssociate ProfessorKathrynWeaverKathryn E. Weaver PhD36.09550200000000-80.24393700000000515Weaver, KathrynProfessorLuisBarrosoLuis F. Barroso MD36.09032400000000-80.26649100000000565Barroso, LuisAssociate ProfessorLanceMillerLance D. Miller PhD, MS36.09032400000000-80.26649100000000574Miller, LanceAssistant ProfessorMichaelChanMichael D. Chan MD36.09103700000000-80.26909600000000614Chan, MichaelAssistant ProfessorMarkChappellMark C. Chappell PhD36.09032400000000-80.26649100000000616Chappell, MarkProfessorPaulSavagePaul D. Savage MD36.08919100000000-80.26677800000000775Savage, PaulAssociate ProfessorStevenFeldmanSteven R. Feldman MD, PhD36.08959100000000-80.26859900000000884Feldman, StevenProfessor25613118Lewis JA, Petty WJ, Tooze JA, Miller DP, Chiles C, Miller AA, Bellinger C, Weaver KECancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyLewis JA, Petty WJ, Tooze JA, Miller DP, Chiles C, Miller AA, Bellinger C, Weaver KE. Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):664-70.Cancer Epidemiol Biomarkers Prev2015-01-22T00:00:002015Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center.25815292Ruiz J, Petty WJAnnals of translational medicineRuiz J, Petty WJ. Clinical perspective on PROSE: does VeriStrat testing improve selection of second-line treatment for patients with non-small cell lung cancer? Ann Transl Med. 2015 Mar; 3(3):31.Ann Transl Med2015-03-01T00:00:002015Clinical perspective on PROSE: does VeriStrat testing improve selection of second-line treatment for patients with non-small cell lung cancer?Authorship 42113224576944Lewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersLewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJ. Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone. J Oncol Pharm Pract. 2015 Jun; 21(3):220-3.J Oncol Pharm Pract2014-02-27T00:00:002014Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone.Authorship 436042Authorship 436132Authorship 460061Authorship 46056326917042Sadri-Ardekani H, McLean TW, Kogan S, Sirintrapun J, Crowell K, Yousif MQ, Hodges SJ, Petty J, Pranikoff T, Sieren L, Zeller K, Atala AMethods (San Diego, Calif.)Sadri-Ardekani H, McLean TW, Kogan S, Sirintrapun J, Crowell K, Yousif MQ, Hodges SJ, Petty J, Pranikoff T, Sieren L, Zeller K, Atala A. Experimental testicular tissue banking to generate spermatogenesis in the future: A multidisciplinary team approach. Methods. 2016 Apr 15; 99:120-7.Methods2016-02-23T00:00:002016Experimental testicular tissue banking to generate spermatogenesis in the future: A multidisciplinary team approach.Authorship 48413826929893Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJCureusKilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJ. Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)? Cureus. 2016 Jan 23; 8(1):e466.Cureus2016-01-23T00:00:002016Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?Authorship 489091026725964Kilburn JM, Soike MH, Lucas JT, Ayala-Peacock D, Blackstock W, Isom S, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJPractical radiation oncologyKilburn JM, Soike MH, Lucas JT, Ayala-Peacock D, Blackstock W, Isom S, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients. Pract Radiat Oncol. 2016 May-Jun; 6(3):e73-e80.Pract Radiat Oncol2015-10-22T00:00:002015Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.Authorship 50505327732654Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz JPloS oneLycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J. A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma. PLoS One. 2016; 11(10):e0164244.PLoS One2016-10-12T00:00:002016A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.27893433Hu Y, Feng X, Mintz A, Petty WJ, Hsu WOncotargetHu Y, Feng X, Mintz A, Petty WJ, Hsu W. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer. Oncotarget. 2016 Dec 27; 7(52):87124-87135.Oncotarget2016-12-27T00:00:002016Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.27895527Savage PD, Lovato J, Brosnihan KB, Miller AA, Petty WJSarcomaSavage PD, Lovato J, Brosnihan KB, Miller AA, Petty WJ. Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma. Sarcoma. 2016; 2016:4592768.Sarcoma2016-11-08T00:00:002016Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.Authorship 52501427559623Duggan KT, Hildebrand Duffus S, D'Agostino RB, Petty WJ, Streer NP, Stephenson RCJournal of palliative medicineDuggan KT, Hildebrand Duffus S, D'Agostino RB, Petty WJ, Streer NP, Stephenson RC. The Impact of Hospice Services in the Care of Patients with Advanced Stage Nonsmall Cell Lung Cancer. J Palliat Med. 2017 01; 20(1):29-34.J Palliat Med2016-08-25T00:00:002016The Impact of Hospice Services in the Care of Patients with Advanced Stage Nonsmall Cell Lung Cancer.Authorship 53584828401684Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MDCancer medicineShenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017 May; 6(5):944-952.Cancer Med2017-04-12T00:00:002017The Effects of smoking status and smoking history on patients with brain metastases from lung cancer.ChristopherSchaichChristopher L. Schaich PhD36.09032400000000-80.266491000000002062Schaich, ChristopherAssistant ProfessorAuthorship 543838Authorship 543844Authorship 543855Authorship 54386328472989Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang WJournal of hematology & oncologyYang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang W. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. J Hematol Oncol. 2017 05 04; 10(1):100.J Hematol Oncol2017-05-04T00:00:002017Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.29761297Mancone S, Lycan T, Ahmed T, Topaloglu U, Dothard A, Petty WJ, Strowd REJournal of neurologyMancone S, Lycan T, Ahmed T, Topaloglu U, Dothard A, Petty WJ, Strowd RE. Severe neurologic complications of immune checkpoint inhibitors: a single-center review. J Neurol. 2018 Jul; 265(7):1636-1642.J Neurol2018-05-14T00:00:002018Severe neurologic complications of immune checkpoint inhibitors: a single-center review.Authorship 584775Authorship 60600630005982Ruiz J, Miller AA, Tooze JA, Crane S, Petty WJ, Gajra A, Klepin HDJournal of geriatric oncologyRuiz J, Miller AA, Tooze JA, Crane S, Petty WJ, Gajra A, Klepin HD. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol. 2019 01; 10(1):48-54.J Geriatr Oncol2018-07-10T00:00:002018Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.Authorship 648501Authorship 666734Authorship 667939Authorship 66798230655905Bonomi M, Ahmed T, Addo S, Kooshki M, Palmieri D, Levine BJ, Ruiz J, Grant S, Petty WJ, Triozzi PLOncology lettersBonomi M, Ahmed T, Addo S, Kooshki M, Palmieri D, Levine BJ, Ruiz J, Grant S, Petty WJ, Triozzi PL. Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis. Oncol Lett. 2019 Jan; 17(1):1349-1356.Oncol Lett2018-11-19T00:00:002018Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.23036317Petty W, Miller G, Burstein AOrthopaedics & traumatology, surgery & research : OTSRPetty W, Miller G, Burstein A. Commentary on an article by C.-E. Thelu et al.: "poor results of the Optetrak(TM) cemented posterior stabilized knee prosthesis after a mean 25-month follow-up: analysis of 110 prostheses". Orthop Traumatol Surg Res. 2012 Oct; 98(6):706-8.Orthop Traumatol Surg Res2012-10-01T00:00:002012Commentary on an article by C.-E. Thelu et al.: "poor results of the Optetrak(TM) cemented posterior stabilized knee prosthesis after a mean 25-month follow-up: analysis of 110 prostheses".31360617Nightingale CL, Steffen LE, Tooze JA, Petty W, Danhauer SC, Badr H, Weaver KEGlobal advances in health and medicineNightingale CL, Steffen LE, Tooze JA, Petty W, Danhauer SC, Badr H, Weaver KE. Lung Cancer Patient and Caregiver Health Vulnerabilities and Interest in Health Promotion Interventions: An Exploratory Study. Glob Adv Health Med. 2019; 8:2164956119865160.Glob Adv Health Med2019-07-17T00:00:002019Lung Cancer Patient and Caregiver Health Vulnerabilities and Interest in Health Promotion Interventions: An Exploratory Study.30656089Lewis JA, Petty WJ, Urbanic J, Bernstein ED, Ahmed TCureusLewis JA, Petty WJ, Urbanic J, Bernstein ED, Ahmed T. Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature. Cureus. 2018 Nov 13; 10(11):e3586.Cureus2018-11-13T00:00:002018Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature.24Assistant Professor23842552Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MDNeurosurgeryKuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013 Oct; 73(4):641-7; discussion 647.Neurosurgery2013-10-01T00:00:002013Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery.Cardiothoracic Surgery Internal Medicine, Cardiovascular MedicineInternal Medicine, Hematology & OncologyInternal Medicine, Infectious DiseasesPhysiology & PharmacologySocial Sciences & Health Policy (Public Health Sciences)Surgery, HypertensionSurgery, OncologyUrologyhttps://wakencorp.phs.wakehealth.edu/Wake Forest NCORP Research Base24100924Petty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, Weaver KE, Miller AAInternational journal of oncologyPetty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, Weaver KE, Miller AA. Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer. Int J Oncol. 2013 Dec; 43(6):2057-63.Int J Oncol2013-10-03T00:00:002013Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer.2ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 272221Authorship 29336Authorship 37402Authorship 49641Authorship 5439218247132Voelzke WR, Petty WJ, Lesser GJCurrent treatment options in oncologyVoelzke WR, Petty WJ, Lesser GJ. Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr Treat Options Oncol. 2008 Feb; 9(1):23-31.Curr Treat Options Oncol2008-02-05T00:00:002008Targeting the epidermal growth factor receptor in high-grade astrocytomas.20035186Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AWJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerCenter B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AW. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5(1):69-74.J Thorac Oncol2010-01-01T00:00:002010A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.21555162Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KHLung cancer (Amsterdam, Netherlands)Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH. High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer. Lung Cancer. 2011 Dec; 74(3):384-91.Lung Cancer2011-05-08T00:00:002011High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.22963500Petty WJ, Aklilu M, Varela VA, Lovato J, Savage PD, Miller AABMC cancerPetty WJ, Aklilu M, Varela VA, Lovato J, Savage PD, Miller AA. Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1a in vascular sarcomas. BMC Cancer. 2012 Sep 11; 12:404.BMC Cancer2012-09-11T00:00:002012Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1a in vascular sarcomas.23045594Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DEJournal of clinical oncology : official journal of the American Society of Clinical OncologySocinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE. Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol. 2012 Nov 10; 30(32):3953-9.J Clin Oncol2012-10-08T00:00:002012Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.D002289Disorders38910.920111Carcinoma, Non-Small-Cell LungD009383Disorders570.994684Neoplasms, Vascular TissueD007720Devices11140.987709Knee ProsthesisD008175Disorders1143740.740176Lung NeoplasmsD011799Chemicals & Drugs18300.983204Quinazolines